StreetAlpha.app
Home › Stocks › GRDN

Guardian Pharmacy Services, Inc. (GRDN)

$46.94
▲ +0.58%
LAST CLOSE · NOV 20

Guardian Pharmacy Services provides pharmacy dispensing and medication management services to residents of long term care facilities. It last closed at $46.94 on Nov 20, up 0.58% on the day. The next earnings report for GRDN is expected around Tue, Jan 12, 2027, after the close. For the quarter ended Sep 2026, GRDN reported EPS of $0.29 on revenue of $371.1M, with revenue down 1.7% from a year ago. Over its last 8 reports the stock moved an average of 5.7% the session after earnings. Over the last 12 months GRDN insiders bought $100K of stock on the open market and sold $419.5M, according to SEC Form 4 filings.

AI Auto Pilots
Is GRDN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold GRDN.

Key Stats

Last 12 months
Results
Revenue
$1.5B
+4.9% vs a year ago
Net income
$74.8M
+85.8% vs a year ago
Gross margin
22.4%
$327.1M gross profit
Operating margin
6.5%
$94.1M operating income
Balance sheet
Cash & equivalents
$119.7M
At Sep 30
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2024: $1.2B$1.2BFY2024FY2025: $1.4B$1.4BFY2025

From GRDN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Jan 12
Estimated date · After the close
Reported EPS
$0.29
Quarter ended Sep 2026
Year ago EPS
$0.15
+93.3% on a GAAP basis
Revenue
$371.1M
−1.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Sep 2025: $0.15Sep '25Sep 2026: $0.29Sep '26Latest $0.29
Revenue by quarter
Dec 2024: $338.6MDec '24Mar 2025: $329.3MMar '25Jun 2025: $344.3MJun '25Sep 2025: $377.4MSep '25Dec 2025: $397.6MDec '25Mar 2026: $336.6MMar '26Jun 2026: $351.8MJun '26Sep 2026: $371.1MSep '26Latest $371.1M
How GRDN moved after its last 8 reports
Average move the session after a report ±5.7%
Nov 5, 2026After the close+6.3%
Aug 6, 2026After the close+11.1%
May 6, 2026After the close−0.8%
Mar 11, 2026After the close−0.7%
Jan 13, 2026After the close−3.6%
Nov 10, 2025After the close+5.0%
Aug 11, 2025After the close+13.8%
May 12, 2025After the close−4.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on GRDNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on GRDN
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on GRDN

Technical Analysis

GRDN · as of the Nov 20 close · updated each morning
Uptrend

The stock is 5% above its 20 day and 8% above its 50 day average. It is 16% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 57). The nearest support is the Pivot at $46.85, and the nearest resistance the swing high (Aug 7) at $47.02.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 4.2%/day
Key levels
$50.8552 week high+8.3%
$47.57Pivot R1+1.3%
$47.02Swing high (Aug 7)+0.2%
$46.94Last close
$46.85Pivot−0.2%
$46.22Pivot S1−1.5%
$44.6720 day average−4.8%
$43.0450 day average−8.3%
$41.51100 day average−11.6%
$40.04Swing low (Oct 1)−14.7%
$39.27200 day average−16.3%
$26.3452 week low−43.9%
Indicators
RSI (14)57.18Middle of its rangeNeutral
MACD2.04Above its signal lineBullish
Stochastic70.5Middle of its rangeNeutral
ADX (14)27.4Trending up
Williams %R-34.3Oversold below −80, overbought above −20Neutral
CCI (20)37.9Oversold below −100, overbought above 100Neutral
Rate of change+10.7%Change over 10 sessionsBullish
ATR (14)$1.95Typical daily range, 4.2% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for GRDN

What happened before

See how GRDN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for GRDNHow many large options trades hit GRDN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

GRDN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲109 buying vs 82 selling
  • ▲Shares held by funds +2.0%
  • ▲Funds holding +8
  • ▼Superinvestors: 0 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding197189+4.2%
In funds' top 1012−50.0%
Held by funds–––
New / increased29 / 8034 / 73+1.9%
Reduced / sold out59 / 2353 / 15+20.6%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See GRDN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

GRDN Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$100K1 buy · 1 insider
Sold$419.5M10 sales · 10 insiders
2025-12 bought $100K2026-03 sold $419.2M2026-11 sold $251KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 17David Norman MartinSee RemarksSale5,000$50.25$251K
Mar 20Cardinal Equity Fund, L.P.InsiderSale275,728$29.68$8.2M
Mar 20Kendall ForbesSee RemarksSale346,672$29.68$10.3M
Mar 20William E BindleyDirectorSale3,570,677$29.68$106.0M
Mar 20John AckermanDirectorSale1,103,364$29.68$32.7M
Mar 20Bindley Capital Partners I, LLC10% ownerSale3,570,677$29.68$106.0M
Every insider buy and sale for GRDN over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See GRDN insider trades →

From SEC Form 4 filings by GRDN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GRDN is in one of them and how their past GRDN trades turned out.

GRDN in the AI portfolios
Loading…

GRDN News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered GRDN in an article yet. Here's the latest on the wider market.

GRDN in the news

About Guardian Pharmacy Services

Guardian Pharmacy Services is a pharmacy services company based in Atlanta, Georgia. It dispenses, packages and delivers prescription medications to residents of long term care facilities, with a focus on assisted living facilities and behavioral health facilities. Its services include compliance packaging, automated robotic dispensing, medication administration training for facility staff and drug regimen reviews. Its customers include the residents, the facilities that house them and health plan payors.

Headquarters
Atlanta, GA